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Abstract. To better understand the factors involved in maternal–fetal transmission of Trypanosoma cruzi, we com-
pared DNA levels—obtained by use of quantitative real-time PCR and parasitic genotypes determined by PCR ampli-
fication followed by hybridization—in Bolivian mothers and their congenitally infected newborns. Mothers and their
neonates displayed markedly different parasitic DNA levels, as most maternal estimated parasitemias (> 90%) were
< 10 parasites/mL, whereas those of 76% of their newborns were > 1,000 parasites/mL. Comparison of T. cruzi TcII
sublineages infecting mothers and newborns showed identity, without evidence of mixed infection in mothers or neo-
nates. Analysis of minor variants of TcIId-genotyped parasites using sequence class probes hybridizing with hypervari-
able domains of kDNA minicircles showed discrepancies in half of mother/newborn pairs.
INTRODUCTION
The protozoan parasite Trypanosoma cruzi, agent of Cha-
gas disease, infects 16–18 million people in Latin America.
Parasites are mainly transmitted by blood-sucking vector bugs
releasing excreta containing infectious agents, transfusion of
infected blood, or congenitally from mothers to their fetuses.1
In endemic countries where national programs of vectorial
control and selection of blood donors have been developed,
maternal–fetal transmission of parasites has evolved as the
most important route of T. cruzi infection, making possible
transmission from one generation to another.2,3
Such transmission occurs in 1–12% of infected mothers,
and morbidity and mortality of congenital infection vary from
asymptomatic to severe and mortal clinical forms of dis-
ease.3,4 Host as well as parasitic factors might be involved in
such variations. Indeed, recent studies have highlighted asso-
ciations between a higher frequency of positive hemocultures
in infected mothers and their lower capacity to develop a
parasite-specific immune response and congenital infection.5
We have also recently shown that neonates could be infected
with T. cruzi of various nDNA genotypes, such as TcIIb,
TcIId, and TcIIe sublineages, and with kDNA variants of the
TcIId sublineage, independently of their parasitemia or clini-
cal status, indicating that the DNA polymorphism of T. cruzi,
at least of type TcIId, was not associated with the clinical
diversity of congenital infection.6
To better understand the factors involved in the maternal–
fetal transmission of T. cruzi, the present work aims to com-
pare the sublineages of T. cruzi, as well as their DNA levels,
using quantitative real-time PCR (qPCR), in blood of in-
fected mothers and their infected neonates.
MATERIAL AND METHODS
Patients and blood samples. The present work considered
36 newborns congenitally infected with T. cruzi and 15 of
their mothers (from whom samples were available), coming
from the Bolivian regions of Cochabamba (Maternity Ger-
man Urquidi, University Hospital Viedma, “Universidad
Mayor de San Simon”) and Tarija (Maternity Hospital “San
Juan de Dios” and the district hospital of Yacuiba). Clinical
data of such patients have been reported elsewhere.4,6 Um-
bilical cord and maternal venous blood samples were imme-
diately mixed with the same volume of guanidine-HCl 6 M,
EDTA 0.1 M (pH 8), boiled for 15 min, and kept at 4°C until
use. This study has been approved by the scientific/ethic com-
mittees of U.M.S.S. and Université Libre de Bruxelles
(U.L.B.), and written informed consent was obtained from
the mothers before blood collection.
Diagnosis of T. cruzi infection. Maternal infection was as-
sessed using standard T. cruzi-specific serological tests
(ELISA, hemagglutination, and immunofluorescence) per-
formed as previously described.4 Congenital infection with T.
cruzi was assessed by direct microscopic detection of parasites
in blood buffy coat collected in 4–6 centrifuged microhemat-
ocrit heparinized tubes (n  35) or by hemoculture (n  1)
as previously described.4 The detection limit of such parasi-
tological detection was estimated to be 40 parasites/mL.7 The
number of positive microhematocrit tubes containing para-
sites, as well as the number of detected parasites per tube
allowed estimation of parasitemia as either low ( 40 to < 150
p/mL), medium ( 150 to < 400 p/mL), or high ( 400 p/mL).
DNA extraction and standard PCR. DNA was isolated
from 0.2 mL of blood/guanidine solution, using the QIAamp
DNA Blood Mini Kit (Qiagen, Valencia, CA), according to
the manufacturer’s protocol. Purified DNA was dissolved in
200 L of 10 mM Tris-HCl, 1 mM EDTA, pH 8.0, and con-
served at −20°C until use. Presence of T. cruzi DNA in extract
was first tested by standard PCR using primers amplifying
either nDNA (Tcz1/Tcz2, giving amplicons of 200 pb) or ki-
netoplast sequences (Tc121/Tc122, giving amplicons of 320
pb).8
T. cruzi typing. Identification of (sub)lineages of T. cruzi
and of variants of the sublineage TcIId was performed by
hybridization of DNA amplicons resulting from the Tc121/
Tc122 PCR amplification, with oligonucleotides or kDNA
probes as previously described.6 The TcIId variants were
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grouped according to their relative hybridization pattern with
probes Oli-IId-1 and Oli-IId-2 as described by Virreira and
others in 2006.6 Although our TcIIe probe hybridizes also to
some extent with the TcIIb lineage, samples hybridizing with
the TcIIe probe but not with the TcIIb probe are unambigu-
ously typed as the TcIIe sublineage.
Quantitative real-time PCR (qPCR). Assays of qPCR were
performed using the SYBR Green system (Roche Applied
Science, Mannheim, Germany) in a LightCycler 2.0 System
(Roche), according to the manufacturer’s instructions and us-
ing kDNA S35/S36 modified primers as previously de-
scribed.9 However, the hybridization temperature of the am-
plification program was increased from 57°C (as described by
Cummings and Tarleton in 20039) to 63 or 65°C, to delay the
appearance of unspecific bands (background) originating
from human DNA.10 All samples were analyzed in duplicate,
in at least two separate experiments. Under standard condi-
tions, the reaction medium (10 L final volume) was pre-
pared in glass capillaries mixing 2 L of LightCycler FastStart
DNA Master SYBR Green I buffer containing Taq poly-
merase, 0.8 L of 25 mM MgCl2, 0.5 L of each 10 M
S35/S36 modified primers, 5.2 L of sterile water, and 1 L of
template DNA. Standard curves were performed using 10-
fold serial dilutions of an initial suspension of 105 parasites
(trypomastigote form) in 1 mL of a mixture containing 0.5 mL
of human blood and 0.5 mL of 6 M guanidine-HCl, 0.1 M
EDTA, pH 8, and boiled for 10 minutes. The reaction mix was
centrifuged in a Roche LightCycler Carousel Centrifuge 2.0
before amplification with the following program: denatur-
ation phase of 95°C for 15 minutes and 40 cycles of 95°C for
10 sec, 63°C for 10 sec, and 72°C for 5 sec.
RESULTS
Evaluation of qPCR in detecting T. cruzi DNA levels in
blood samples. Reproducible agreement between the number
of cycles of qPCR and the number of parasites per assay was
obtained using the serial dilutions of parasites in human
blood. Figure 1A shows values of a standard curve performed
at a hybridization temperature of 63°C, allowing reliable de-
tection down to 0.001–10 parasites DNA equivalent/assay,
corresponding to 2–20,000 parasites/mL of blood. Unspecific
background amplification, obtained with various negative
blood samples, resulted in a crossing point of 27 cycles or
more (dashed area in Figure 1A). The crossing point of the
lowest concentration tested (0.001 parasite/assay) was ≈ 1
cycle less than the crossing point of negative controls. By
increasing the hybridization temperature to 65°C, the crossing
point of the cycle number corresponding to the background
was increased to 30 cycles, and the lowest concentration
tested resulted in a crossing point ≈ 2 cycles less than the
crossing point of negative controls. Consequently, this last
condition (hybridization temperature of 65°C) allowed better
appreciation of very low parasitemia.
Fluorescence intensities of amplicons obtained after stan-
dard PCR (performed using both nDNA Tcz1-Tcz2 and
kDNA Tc121/122 primers) and the qPCR in blood samples of
infected individuals were compared. Figure 1, B and C, shows
good agreement between fluorescence intensities of ampli-
cons in standard PCR and qPCR.
Determination of T. cruzi DNA blood levels in congeni-
tally infected newborns and their mothers. The 36 studied
umbilical cord blood samples of congenital cases were posi-
tive in the standard Tcz1-Tcz2 PCR.8 Determination of para-
sitic DNA levels by qPCR indicated parasitemias ranging be-
tween 6 and 55,600 parasites/mL in these samples. Figure 2
shows the distribution of such parasitic load, indicating that
76.3% of these blood samples contained > 1,000 parasites/mL.
As shown in Figure 3, agreement was observed between the
qPCR data and the semiquantitative estimation of para-
sitemia performed by microscopic analysis of capillary tubes.
Three umbilical cord blood samples of these confirmed con-
genital cases harbored a qPCR-estimated parasitemia of < 40
parasites/mL: 2 were detected positive by direct microscopic
examination, and the third was positive after hemoculture but
negative by microscopic examination.
The standard Tcz1-Tcz2 PCR was positive in all 15 of the
available blood samples from mothers of congenitally in-
fected newborns. Quantitative PCR performed in these
samples showed parasitic DNA levels much lower than those
of their infected newborns, corresponding to 2–12 parasites/
mL. Fourteen of the 15 mothers (93.3%) displayed para-
sitemias < 10 parasites/mL. There was correlation neither be-
tween maternal and neonatal qPCR-estimated parasitemias
nor between T. cruzi-specific antibody maternal levels and
estimated maternal or neonatal parasitemias (P > 0.05).
FIGURE 1. Amplification of T. cruzi DNA extracted from human
blood. (A) Standard curve of qPCR using the SYBR Green system
(Roche) in the LightCycler apparatus performed at a hybridization
temperature of 63°C with blood artificially infected with known
amounts of parasites. A background of unspecific amplification of
various negative samples was observed at > 27 cycles (dashed area).
(B) Amplification curves of DNA extracted from various blood
samples. Fluorescence was recorded after each cycle. CM stands for
“mothers”; CB stands for “baby.” (C) Classic PCR of DNA extracted
from the same samples as in (B), using the GoTaq polymerase kit
(Promega, Madison, WI). Amplicons were separated on TAE 1.2%
agarose gel in the presence of ethidium bromide (0.50 g/mL).
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T. cruzi typing in infected mothers and newborns. Data of
T. cruzi typing of the 36 studied umbilical cord blood samples
of congenital cases were reported previously.6 Briefly, 34
samples were infected with the TcIId sublineage (94.4%),
whereas 2 other samples harbored the sublineages TcIIb and
TcIIe. Fifteen mothers of the above-mentioned neonates
showed 14 (93.3%) and 1 (6.7%) infected with the TcIId and
TcIIe sublineages, respectively. Mixed infections with differ-
ent T. cruzi sublineages were detected neither in mothers nor
in fetuses. Comparison of such T. cruzi typing in the 15
mother/neonate pairs showed the parasitic sublineages being
identical in all mothers and their newborns (14 pairs infected
with TcIId and 1 pair infected with TcIIe).
The complementary kDNA genotyping of the 14 mother/
neonate pairs harboring the TcIId sublineage showed 7
mother/neonate pairs displaying an identical pattern of hy-
bridization with both oligonucleotide Oli-TcIId-1 and Oli-
TcIId-2 probes, indicating the presence of similar TcIId vari-
ants in both samples (Figure 4A). The 7 other mother/
neonate pairs displayed markedly different relative patterns
of hybridization with the Oli-TcIId-1 and Oli-TcIId-2 probes,
indicating that these mothers and their neonates were in-
fected with different TcIId variants (Figure 4B).
DISCUSSION
Altogether, our results show that 1) mothers display low
parasitic DNA levels, corresponding to parasitemia < 10 para-
sites/mL in 90% of them, whereas their newborns displayed
high DNA levels corresponding to parasitemia levels > 1,000
parasites/mL in more than 76% of them; 2) comparison of T.
cruzi sublineages infecting mothers and their newborns
FIGURE 2. Distribution of parasitemias estimated from DNA lev-
els in umbilical cord blood. DNA of 36 samples of umbilical blood of
congenitally infected babies was extracted and amplified by qPCR
(see Materials and Methods).
FIGURE 3. Agreement between parasitemias in umbilical cord of
T. cruzi congenitally infected newborns as estimated by qPCR and
microscopic examination of centrifuged capillary tubes. Results are
expressed in geometric means ± SEM; n  number of samples.
FIGURE 4. Relative hybridization with oligonucleotides probes of
amplicons isolated from maternal and umbilical cord blood. (A)
Samples presenting identical patterns of relative hybridization with
oligonucleotides Oli-IId-1 and Oli-IId-2. (B) Samples presenting dif-
ferent patterns of relative hybridization with oligonucleotides Oli-
IId-1 and Oli-IId-2.
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(TcIId and TcIIe) showed identity without evidence of mixed
infection in mothers or in neonates; 3) comparison of minor
variants of TcIId showed discrepancies in half of mother/
newborn pairs.
Our data emphasize the capacity of qPCR to estimate T.
cruzi DNA levels directly from human blood, as was also the
case in amniotic fluid, as previously shown.10 In our experi-
mental conditions, the limit of detection of qPCR could be
estimated to 2 parasites/mL of blood using a hybridization
temperature of 65°C (i.e., a detection limit similar to that of
the standard Tcz1-Tcz2 PCR that we used for qualitative ap-
preciation of the presence of parasitic DNA).8 By contrast,
the microscopic examination of parasites concentrated in cap-
illary tubes allows to detect parasitemia  40 parasites/mL.7
Although the parasite detection threshold of PCR tech-
niques is low, it is important to note that such procedures
detect parasitic DNA without giving information on parasite
viability, whereas the above-mentioned parasitological
method indicates unambiguously the presence of live para-
sites. Indeed, PCR detection of low levels of parasitic DNA
could correspond to debris of dead parasites not yet degraded
by host blood DNase, without current infection. In addition,
kDNA of Trypanosomatidae is organized in multiple circles,
probably much more difficult to digest than linear nDNA.
These considerations might complicate the diagnosis by PCR
of congenital infection in newborns, as we may not exclude
that parasitic DNA might be transferred from the mother to
the fetus without the passage of live parasites (i.e., in the
absence of infection), as is likely the case for other parasitic
molecules.11 This has to be kept in mind when interpreting
qPCR results that show low levels of foreign DNA in blood,
and the existence of infection must be confirmed by other
data or other PCR analysis of blood.12 However, qPCR re-
mains a sophisticated and expensive technique useful as an
investigation tool to improve our understanding of the ma-
ternal–fetal transmission of T. cruzi but is hardly applicable in
the control strategies for congenital Chagas disease.2,3
Agreement between parasite levels obtained by qPCR and
parasite counts in capillary tubes highlights the reliability of
detecting parasitic DNA levels to estimate parasitemia. The
high parasitemia observed in > 76% of congenitally infected
neonates confirms the intense parasite multiplication occur-
ring in fetal tissues in this particular form of acute chagasic
infection. However, some neonates also displayed lower para-
sitemia. Such differences could relate to the timing of the first
transplacental transmission of parasites during gestation, a
weaker neonatal parasitism, or the closer to delivery such
transmission might have occurred. Another non-exclusive
possibility lies in the capacity of fetuses/neonates to control
infection. Indeed, it has been previously shown that T. cruzi-
infected fetuses/neonates were able to overcome their physi-
ologic immunologic immaturity by developing a cytotoxic-
and IFN- producing CD8 T-cell response toward parasites.13
Both factors (timing of maternal–fetal parasite transmission
and fetal capacity to develop its own immune response) likely
contribute to explain the absence of a correlation between
maternal and neonatal estimated parasitemia.
Parasitic DNA levels detected in infected mothers were
close to the lower detection limit of qPCR. However, such
low parasitic DNA levels can be considered as corresponding
to living parasites (see above) because high levels of T. cruzi-
specific antibodies were detected in such mothers: half of
them displayed T. cruzi-positive hemocultures,5 and they
have transmitted parasites to their fetuses. These low mater-
nal parasitemias, contrasting with the 100-fold higher parasite
blood levels observed in most neonates, likely relates to the
stronger T. cruzi-specific immune response developed by
such chronically infected mothers than in their fetuses/
neonates.5,13
The T. cruzi typing of blood samples of congenital cases
and of some mothers confirmed previous data that we and
others obtained, indicating the sublineage TcIId as largely
distributed in the Bolivian population6,14 and that various
(sub)lineages of T. cruzi can be involved in congenital cha-
gasic infection.6 A remarkable result of the present study
comes from the comparison of T. cruzi genotypes infecting
the mothers and their neonates, which shows similar (sub)lin-
eages (TcIId, TcIIe) in all mother/neonate pairs, whereas dif-
ferent minor kDNA variants of the TcIId sublineage were
found in half of such pairs. The observation of parasite geno-
types similar in both mothers and newborns is the expected
result in case of maternal infection with only 1 parasite geno-
type directly transmitted to the fetus. Discrepancies between
the T. cruzi genotypes observed in mothers and their new-
borns, as observed for minor TcIId kDNA variants, can be
differently interpreted. One hypothesis relates to maternal
infection with only 1 parasite genotype that is transmitted to
the fetus. A much more intense parasite multiplication occur-
ring in the infected fetuses in comparison to mothers would
allow susceptible mutations to rapidly generate new variants
detected in the neonates, although contradictory data have
been reported about the mutation rates in the hypervariable
regions in kDNA minicircles.15,16 Another possible interpre-
tation of such discrepancies relates to possible mixed mater-
nal infections with various TcIId variants (which cannot be
excluded using our protocol), followed by either a transpla-
cental passage of only one of these variants to be transmitted
to the fetus or by a transplacental transmission of various
variants and a more rapid multiplication of one of these vari-
ants becoming dominant in fetus. Interestingly, previous his-
topathologic studies of placentas performed by our team in-
dicated that parasite multiplication occurred in the chorionic
plate and the membranal chorion (i.e., within regular cells for
T. cruzi multiplication), without invasion of trophoblastic
villi3,17 (and unpublished data), suggesting that the capacity of
placenta to select the parasite genotype during maternal–fetal
transmission is probably limited.
In conclusion, comparison of parasitic features in infected
mothers and their newborns highlights the contrasting levels
of high parasitemia observed in neonates and the low para-
sitemia detected in their mothers. Mixed infections by various
sublineages were detected neither in mothers nor in neonates,
and these sublineages of T. cruzi were found to be identical in
mothers and their neonates. However, further studies will be
necessary to clarify the mechanism leading to the detection of
different minor T. cruzi variants in mothers and their neo-
nates using probes hybridizing with hypervariable domains of
kDNA minicircles.
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